다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
PloS one, v.5 no.10, 2010년, pp.e13460 -
Corbett, Holly J. (Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia) , Fernando, Germain J. P. (Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia) , Chen, Xianfeng (Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia) , Frazer, Ian H. (Diamantina Institute, Princess Alexandra Hospital, The University of Queensland, Woolloongabba, Queensland, Australia) , Kendall, Mark A. F. (Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia)
AI-Helper
BackgroundBetter delivery systems are needed for routinely used vaccines, to improve vaccine uptake. Many vaccines contain alum or alum based adjuvants. Here we investigate a novel dry-coated densely-packed micro-projection array skin patch (Nanopatch™) as an alternate delivery system to intramuscul...
1 Prüss-Üstün A Rapiti E Hutin Y 2005 Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med 48 482 490 16299710
2 Miller MA Pisani E 1999 The cost of unsafe injections. Bull World Health Organ 77 808 811 10593028
3 Simonsen L Kane A Lloyd J Zaffran M Kane M 1999 Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 77 789 800 10593026
4 Hamilton JG 1995 Needle phobia: a neglected diagnosis. J Fam Pract 41 169 175 7636457
5 Nir Y Paz A Sabo E Potasman I 2003 Fear of injections in young adults: prevalence and associations. Am J Trop Med Hyg 68 341 344 12685642
6 Schuler G Steinman RM 1985 Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 161 526 546 3871837
7 López-Bravo M Ardavín C 2008 In Vivo Induction of Immune Responses to Pathogens by Conventional Dendritic Cells. Immunity 29 343 351 18799142
8 Kendall M 2006 Engineering of needle-free physical methods to target epidermal cells for DNA vaccination. Vaccine 24 4651 4656 16162368
9 Mitragotri S 2005 Immunization without needles. Nat Rev Immunol 5 905 916 16239901
10 Fernando GJP Chen X Prow TW Crichton ML Fairmaid EJ 2010 Potent Immunity to Low Doses of Influenza Vaccine by Probabilistic Guided Micro-Targeted Skin Delivery in a Mouse Model. PLoS ONE 5 e10266 20422002
11 Crichton ML Ansaldo A Chen X Prow TW Fernando GJP 2010 The effect of strain rate on the precision of penetration of shortly densely-packed microprojection array patches coated with vaccine. Biomaterials doi: 10.1016/j.biomaterials.2010.02.022
12 Gupta RK 1998 Aluminum compounds as vaccine adjuvants. Adv Drug Deliver Rev 32 155 172
13 Baylor NW Egan W Richman P 2002 Aluminum salts in vaccines—US perspective. Vaccine 20 S18 S23 12184360
14 Kundi M 2007 New hepatitis B vaccine formulated with an improved adjuvant system. Expert Rev Vaccines 6 133 140 17408363
15 Osorio JE Zuleger CL Burger M Chu QL Payne LG 2003 Immune responses to hepatitis B surface antigen following epidermal powder immunization. Immunol Cell Biol 81 52 58 12534946
16 Maa YF Shu C Ameri M Zuleger C Che J 2003 Optimization of an alum-adsorbed vaccine powder formulation for epidermal powder immunization. Pharm Res 20 969 977 12880281
17 Maa Y-F Zhao L Payne L G Chen D 2003 Stabilization of alum-adjuvanted vaccine dry powder formulations: Mechanism and application. J Pharm Sci 92 319 332 12532382
18 Mizuno K Ishihara Y Kawahara T Ohtomo N 1989 Hepatitis B vaccine and method for its preparation. European Patent # 0130619
19 Shinje G Neil DC John WK Jenson AB 1991 Comparison of neutralization of BPV-1 infection of C127 cells and bovine fetal skin xenografts. Int J Cancer 49 285 289 1715330
20 Jan MMW Marcel VJ Manos MM Bosch FX Kummer JA 1999 Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 12 19 10451482
21 Zhou J Sun XY Stenzel DJ Frazer IH 1991 Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 185 251 257 1656586
22 Kirnbauer R Taub J Greenstone H Roden R Durst M 1993 Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol 67 6929 6936 8230414
23 Werness BA Levine AJ Howley PM 1990 Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248 76 79 2157286
24 Phelps WC Yee CL Münger K Howley PM 1988 The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53 539 547 2836062
25 Scheffner M Werness BA Huibregtse JM Levine AJ Howley PM 1990 The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63 1129 1136 2175676
26 Group TFIS 2007 Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356 1915 1927 17494925
27 Lowy DR Schiller JT 2006 Prophylactic human papillomavirus vaccines. J Clin Invest 116 1167 1173 16670757
28 Paavonen J Naud P Salmerón J Wheeler CM Chow SN 2009 Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. The Lancet 374 301 314
29 Hillard W Stuart B Willard C Jr 2004 Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000. Perspect Sex Repro H 36 6 10
30 Winer RL Lee S-K Hughes JP Adam DE Kiviat NB 2003 Genital Human Papillomavirus Infection: Incidence and Risk Factors in a Cohort of Female University Students. Am J Epidemiol 157 218 226 12543621
31 O'Connor K 2007 Herd immunity. Aust Fam Physician 36 677 17915372
32 Dunne EF Unger ER Sternberg M McQuillan G Swan DC 2007 Prevalence of HPV Infection Among Females in the United States. JAMA 297 813 819 17327523
33 Yuan H Estes PA Chen Y Newsome J Olcese VA 2001 Immunization with a Pentameric L1 Fusion Protein Protects against Papillomavirus Infection. J Virol 75 7848 7853 11483728
34 Suzich JA Ghim SJ Palmer-Hill FJ White WI Tamura JK 1995 Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. P Natl Acad Sci USA 92 11553 11557
35 Finch JT Klug A 1965 The structure of viruses of the papilloma-polyoma type: III. Structure of rabbit papilloma virus with an appendix on the topography of contrast in negative-staining for electron-microscopy. J Mol Biol 13 1 12, IN11-IN17 4159383
36 Baker TS Newcomb WW Olson NH Cowsert LM Olson C 1991 Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys J 60 1445 1456 1663794
37 McCarthy MP White WI Palmer-Hill F Koenig S Suzich JA 1998 Quantitative Disassembly and Reassembly of Human Papillomavirus Type 11 Viruslike Particles In Vitro. J Virol 72 32 41 9420197
38 Lenz P Day PM Pang Y-YS Frye SA Jensen PN 2001 Papillomavirus-Like Particles Induce Acute Activation of Dendritic Cells. J Immunol 166 5346 5355 11313370
39 Thones N Herreiner A Schadlich L Piuko K Muller M 2008 A Direct Comparison of Human Papillomavirus Type 16 L1 Particles Reveals a Lower Immunogenicity of Capsomeres than Viruslike Particles with Respect to the Induced Antibody Response. J Virol 82 5472 5485 18385253
40 Shank-Retzlaff ML Zhao Q Anderson C Hamm M High K 2006 Evaluation of the thermal stability of Gardasil. Hum Vaccin 2 147 154 17012891
41 Le Tallec D Doucet D Elouahabi A Harvengt P Deschuyteneer M 2009 Cervarix, the GSK HPV-16/HPV-18 AS04-adjuvanted cervical cancer vaccine, demonstrates stability upon long-term storage and under simulated cold chain break conditions. Hum Vaccin 5 467 474 19377291
42 Chen X Prow TW Crichton ML Jenkins DWK Roberts MS 2009 Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin. J Control Release 139 212 220 19577597
43 Einstein MH Baron M Levin MJ Chatterjee A Edwards RP 2009 Comparison of the immunogenicity and safety of Cervarix() and Gardasil((R)) human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years. Hum Vaccin 5 705 719 19684472
44 Nokleby H 2006 Vaccination and anaphylaxis. Curr Allergy Asthm R 6 9 13
45 World Health Organization Expert Committee on Biological Standardization 2006 Guidelines to assure the quality, safety and efficacy of recombinant human papillomavirus virus-like particle vaccines. Geneva WHO
46 World Health Organization 2008 WHO meeting on the standardization of HPV assays and the role of WHO HPV LabNet in supporting vaccine introduction. Geneva WHO
47 Buck CB Pastrana DV Lowy DR Schiller JT 2006 Generation of HPV Pseudovirions Using Transfection and Their Use in Neutralization Assays. Human Papillomaviruses 445 462
48 Ghim S-j Newsome J Bell J Sundberg JP Schlegel R 2000 Spontaneously Regressing Oral Papillomas Induce Systemic Antibodies That Neutralize Canine Oral Papillomavirus. Exp Mol Pathol 68 147 151 10816383
49 Breitburd F Kirnbauer R Hubbert NL Nonnenmacher B Trin-Dinh-Desmarquet C 1995 Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol 69 3959 3963 7745754
50 Kenney RT Frech SA Muenz LR Villar CP Glenn GM 2004 Dose Sparing with Intradermal Injection of Influenza Vaccine. N Engl J Med 351 2295 2301 15525714
51 Kendall MAF 2005 Device for Delivery of Bioactive Materials and Other Stimuli. WIPO Patent WO 2005/072630, editor
52 Pastrana DV Buck CB Pang Y-YS Thompson CD Castle PE 2004 Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology 321 205 216 15051381
53 Fieller EC 1940 The Biological Standardization of Insulin. Supp J R Stat Soc 7 1 64
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.